Publications by authors named "Philip Clements"

Claim this Profile
F
Factors associated with life satisfaction in systemic sclerosis: Examining the moderating roles of social support and spiritual well-being.
Yen T Chen, Susan L Murphy, Daniel E Furst, Philip Clements, Suzanne Kafaja

J Scleroderma Relat Disord· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts.
Kristofer Andréasson, S Melanie Lee, Venu Lagishetty, Meifang Wu, Natalie Howlett, Philip J Clements

ACR Open Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease.
Shervin Assassi, Ning Li, Elizabeth R Volkmann, Maureen D Mayes, Dennis Rünger, Philip J Clements

Arthritis Rheumatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II.
Elizabeth R Volkmann, Virginia Steen, Ning Li, Michael D Roth, Philip J Clements

ACR Open Rheumatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis.
Elizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, Venu Lagishetty, Philip J Clements

Eur Med J (Chelmsf)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.
Elizabeth R Volkmann, Donald P Tashkin, Michael D Roth, Ning Li, Julio Charles, Philip J Clements

Semin Arthritis Rheum· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach.
Shelley E Condon, Scott C Roesch, Philip J Clements, Daniel E Furst, Michael H Weisman

J Scleroderma Relat Disord· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II.
Elizabeth R Volkmann, Donald P Tashkin, Holly LeClair, Michael D Roth, Grace Kim, Philip J Clements

ACR Open Rheumatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study.
Rina S Fox, Sarah D Mills, Shadi Gholizadeh, Erin L Merz, Scott C Roesch, Philip J Clements

J Scleroderma Relat Disord· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.
Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, Ning Li, Michael D Roth, Philip J Clements

Arthritis Rheumatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Ning Li, Dinesh Khanna, Philip J Clements

J Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining progression of scleroderma-related interstitial lung disease.
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Grace Hyun Kim, Jonathan Goldin, Philip J Clements

J Scleroderma Relat Disord· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.
Murray Baron, Bashar Kahaleh, Elana J Bernstein, Lorinda Chung, Philip J Clements

J Scleroderma Relat Disord· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Ning Li, Ellen Goldmuntz, Philip J Clements

Ann Rheum Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, Holly Wilhalme, Chi-Hong Tseng

Arthritis Res Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
Jonathan G Goldin, Grace Hyun J Kim, Chi-Hong Tseng, Elizabeth Volkmann, Daniel Furst, Philip Clements

Ann Am Thorac Soc· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Sonography findings of synovitis and tenosynovitis of hands and wrists in patients with systemic sclerosis.
Anat Scheiman-Elazary, Veena K Ranganath, Ami Ben-Artzi, Suzanne Kafaja, Nabeel H Borazan, Philip Clements

J Scleroderma Relat Disord· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of minimum standards of care for juvenile localized scleroderma.
Tamás Constantin, Ivan Foeldvari, Clare E Pain, Annamária Pálinkás, Peter Höger, Philip Clements

Eur J Pediatr· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Interesting Case of Neurobrucellosis Mimicking Neuropsychiatric Lupus.
Ramandeep Bains, Tamara Dahhan, Annie Belzowski, Emil R Heinze, Andrew L Wong, Philip J Clements

Case Rep Rheumatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology unknown: Qualitative analysis of patient attributions of causality in scleroderma.
Shadi Gholizadeh, Julia H Drizin, Ingunn Hansdottir, Michael H Weisman, Philip J Clements

J Scleroderma Relat Disord· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
Suzanne Kafaja, Philip J Clements, Holly Wilhalme, Chi-Hong Tseng, Daniel E Furst

Am J Respir Crit Care Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scleroderma renal crisis and renal involvement in systemic sclerosis.
Thasia G Woodworth, Yossra A Suliman, Wendi Li, Daniel E Furst, Philip Clements

Nat Rev Nephrol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.
Philip Clements, Yannick Allanore, Daniel E Furst, Dinesh Khanna

Rheumatology (Oxford)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle involvement in systemic sclerosis: points to consider in clinical trials.
Ulrich A Walker, Philip J Clements, Yannick Allanore, Oliver Distler, Chester V Oddis

Rheumatology (Oxford)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Cyclodextrin- and adamantyl-substituted poly(acrylate) self-assembling aqueous networks designed for controlled complexation and release of small molecules.
Liang Yan, Duc-Truc Pham, Philip Clements, Stephen F Lincoln, Jie Wang

Beilstein J Org Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis